<code id='68ED17D129'></code><style id='68ED17D129'></style>
    • <acronym id='68ED17D129'></acronym>
      <center id='68ED17D129'><center id='68ED17D129'><tfoot id='68ED17D129'></tfoot></center><abbr id='68ED17D129'><dir id='68ED17D129'><tfoot id='68ED17D129'></tfoot><noframes id='68ED17D129'>

    • <optgroup id='68ED17D129'><strike id='68ED17D129'><sup id='68ED17D129'></sup></strike><code id='68ED17D129'></code></optgroup>
        1. <b id='68ED17D129'><label id='68ED17D129'><select id='68ED17D129'><dt id='68ED17D129'><span id='68ED17D129'></span></dt></select></label></b><u id='68ED17D129'></u>
          <i id='68ED17D129'><strike id='68ED17D129'><tt id='68ED17D129'><pre id='68ED17D129'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:explore    Page View:18358
          The FDA building -- First Opinion coverage from STAT
          Adobe

          WASHINGTON — The Food and Drug Administration’s top cancer drug regulator doesn’t always ask for permission before taking on big initiatives.

          Richard Pazdur, director of the FDA Oncology Center of Excellence, hates bureaucracy. It stifles his ideas for getting treatments to cancer patients faster — of which there are many.

          advertisement

          To cut through that bureaucracy, Pazdur has a trick: “Don’t tell anybody,” he said to laughter at a meeting of the advocacy group Friends of Cancer Research Tuesday.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Medical records are filled with copy
          Medical records are filled with copy

          AdobeIrecentlytookcareofapatientwhosemedicalrecordsincludedmultiplenotesaboutherpastopen-heartsurger

          read more
          Ohio still needs to do more to protect the right to abortion
          Ohio still needs to do more to protect the right to abortion

          Issue1supporterscheerastheywatchelectionresultscomein,Tuesday,Nov.7,inColumbus,Ohio.SueOgrocki/APLas

          read more
          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more

          Readout Newsletter: The latest on Amylyx, Moderna, Novavax

          JUSTINTALLIS/AFPviaGettyImagesWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup toge